CancerVax - Crunchbase Company Profile & Funding

Q: Where is CancerVax's headquarters?

CancerVax is located in Rockville, Maryland, United States.

Q: Who invested in CancerVax?

CancerVax has 12 investors including Index Ventures And Merlin Nexus.

Q: When was the last funding round for CancerVax?

CancerVax closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has CancerVax raised to date?

CancerVax has raised obfuscated.

Overview

CancerVax

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About CancerVax

CB Rank

563184

CancerVax is a biotechnology company focused on the research, development and commercialization of novel biological products.

Acquired by

Amgen

Founded

obfuscation

Delisted

Post-IPO Equity

Rockville, Maryland, United States

10001+

www.cancervax.com

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Gordon Ringold: Strategic Advisor
Past Role: SurroMed, Inc, CEO
George Katibah: CSO
Past Role: Rapt, Director of Discovery Biology

Details

Legal Name

Micromet, Inc.

Also Known As

CancerVax

Operating Status

Active

Stock Symbol

NASDAQ:MITI

Company Type

For Profit

About the Company

Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer. Their lead product candidate, Canvaxin, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines.

Phone Number

+490898952770

Predictions & Insights

Products & Services

Universal Cancer Treatment Platform

A cancer immunotherapy platform that detects, marks, and kills cancer cells by making them appear like measles to the immune system.

Ewing Sarcoma Immunotherapy

A targeted immunotherapy treatment for Ewing sarcoma using CAR T-cells and bispecific antibodies to engage the immune system against tumor cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - CancerVax	5	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Index Ventures	—	Post-IPO Equity - CancerVax	—
Index Ventures	—	Post-IPO Equity - CancerVax	—
Index Ventures	—	Post-IPO Equity - CancerVax	—
Index Ventures	—	Post-IPO Equity - CancerVax	—
Index Ventures	—	Post-IPO Equity - CancerVax	—